Overview

Study to Determine the Phototoxity of Atralin (Tretinoin) Gel, 0.05%

Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
To assess the potential of tretnoin gel 0.05% to produce phototoxic reactions, measured as skin reactions 24 and 48 hours after UV radiation of drug on skin.
Phase:
Phase 1
Details
Lead Sponsor:
Coria Laboratories, Ltd.
Treatments:
Tretinoin